ArticleInterleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity
ArticleInterleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity
ArticleClinical and Laboratory Characterization of Systemic Lupus Erythematosus Patients with Activity in Zagazig University Hospitals
ArticleClinical and Laboratory Characterization of Systemic Lupus Erythematosus Patients with Activity in Zagazig University Hospitals
ArticleSERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
ArticleSERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
ArticleEVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS
ArticleEVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS
ArticleSerum interleukin-17 expression in a group of Egyptian patients with juvenile systemic lupus erythematosus
ArticleSerum interleukin-17 expression in a group of Egyptian patients with juvenile systemic lupus erythematosus
ArticleClinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients
ArticleClinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients
ArticleAssessment of Serum Syndecan-1 and its Relation to Renal Involvement in Patients with Systemic Lupus Erythematosus
ArticleAssessment of Serum Syndecan-1 and its Relation to Renal Involvement in Patients with Systemic Lupus Erythematosus